<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HE54D1560AE094CB6A7590047CA9C442D" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2396 IH: Sensible Oversight for Technology which Advances Regulatory Efficiency Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-05-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 2396</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150518">May 18, 2015</action-date> 
<action-desc><sponsor name-id="B001243">Mrs. Blackburn</sponsor> (for herself and <cosponsor name-id="G000410">Mr. Gene Green of Texas</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of health software, and for other purposes.</official-title> 
</form> 
<legis-body id="H1AA6943856364E36B97689C4D91A1302" style="OLC"> 
<section id="H79A9C1F592AF438BAB714F69F70B15F2" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Sensible Oversight for Technology which Advances Regulatory Efficiency Act</short-title></quote> or the <quote><short-title>SOFTWARE Act</short-title></quote>.</text></section> <section id="H3E31998EE37645F999831CA36F2F8D32" commented="no"><enum>2.</enum><header>Health software</header><text display-inline="no-display-inline">Section 201 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>) is amended by adding at the end the following:</text> 
<quoted-block id="H1632C531A55B43C1B028748A05494DA1" style="OLC"> 
<subsection id="H6116D2E6BBF44809A7988111E012CA9A" commented="no"><enum>(ss)</enum> 
<paragraph id="H3FF6B30796BE492D8C6A190E36CCC0DE" display-inline="yes-display-inline" commented="no"><enum>(1)</enum><text display-inline="yes-display-inline">The term <quote>health software</quote> means software that does not, through use of an in vitro diagnostic device or signal acquisition system, acquire, process, or analyze an image or physiological signal, is not an accessory, is not an integral part of a device necessary to support the use of the device, is not used in the manufacture and transfusion of blood and blood components to assist in the prevention of disease in humans, and—</text> <subparagraph id="H7429E443990E44FCB97D6E6D50748FC1" commented="no"><enum>(A)</enum><text display-inline="yes-display-inline">is intended for use for administrative or operational support or the processing and maintenance of financial records;</text></subparagraph> 
<subparagraph id="HEC485D4F34BD4FAC8040432043546056" commented="no"><enum>(B)</enum><text>is intended for use in clinical, laboratory, or administrative workflow and related recordkeeping;</text></subparagraph> <subparagraph id="HC42B6053D7C34C9EB1E965A22600B968" commented="no"><enum>(C)</enum> <clause id="HF59129D518394F7A8941A924259BF463" display-inline="yes-display-inline" commented="no"><enum>(i)</enum><text>is intended for use solely in the transfer, aggregation, conversion (in accordance with a present specification), storage, management, retrieval, or transmission of data or information;</text></clause> 
<clause id="HA23E166199AE43F4AF59AD633E6C02B5" indent="up1" commented="no"><enum>(ii)</enum><text display-inline="yes-display-inline">utilizes a connectivity software platform, electronic or electrical hardware, or a physical communications infrastructure; and</text></clause> <clause id="H779373427DFF46B18F2B4A75084BFB38" indent="up1" commented="no"><enum>(iii)</enum><text display-inline="yes-display-inline">is not intended for use—</text> 
<subclause id="HA26CB76938A547B59FDF7C4DB58C4E5D" commented="no"><enum>(I)</enum><text display-inline="yes-display-inline">in active patient monitoring; or</text></subclause> <subclause id="HF69AAE6BCA5243EBB956D1555D9DC6E4" commented="no"><enum>(II)</enum><text display-inline="yes-display-inline">in controlling or altering the functions or parameters of a device that is connected to such software;</text></subclause></clause></subparagraph> 
<subparagraph id="H7D2D0A0621DC49C6B8154AAEBF2C47D0" commented="no"><enum>(D)</enum><text display-inline="yes-display-inline">is intended for use to organize and present information for health or wellness education or for use in maintaining a healthy lifestyle, including medication adherence and health management tools; </text></subparagraph> <subparagraph id="HCE1C5AC77F7348718F1487A666BEF89A" commented="no"><enum>(E)</enum><text display-inline="yes-display-inline">is intended for use to analyze information to provide general health information that does not include patient-specific recommended options to consider in the prevention, diagnosis, treatment, cure, or mitigation of a particular disease or condition; or</text></subparagraph> 
<subparagraph id="H7F8B63DBF6ED47049E1C7C0EE42284C6" commented="no"><enum>(F)</enum><text display-inline="yes-display-inline">is intended for use to analyze information to provide patient-specific recommended options to consider in the prevention, diagnosis, treatment, cure, or mitigation of a particular disease or condition.</text></subparagraph></paragraph> <paragraph id="H70772AAA7E7F423BB5B39C3AC73B4D35" indent="up1" commented="no"><enum>(2)</enum><text>The term <quote>accessory</quote> means a product that—</text> 
<subparagraph id="HBAA699629F634547AC3286282BD43A7A" commented="no"><enum>(A)</enum><text>is intended for use with one or more parent devices;</text></subparagraph> <subparagraph id="H276D593482954F1EB887AC41D552B45A" commented="no"><enum>(B)</enum><text display-inline="yes-display-inline">is intended to support, supplement, or augment the performance of one or more parent devices; and</text></subparagraph> 
<subparagraph id="HCF903C2B4FFB428AB4C9BA7DD95757DE" commented="no"><enum>(C)</enum><text>shall be classified by the Secretary—</text> <clause id="H9FD55FB1A27246D784CFA1E5568237A1" commented="no"><enum>(i)</enum><text>according to its intended use; and</text></clause> 
<clause id="H70D08147227B4B8A913FE1947EA4F3C0" commented="no"><enum>(ii)</enum><text>independently of any classification of any parent device with which it is used. </text></clause></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section> <section id="H743CA1D5CFD14BA698DC8A53BB9F1BF3" commented="no"><enum>3.</enum><header>Applicability and inapplicability of regulation</header><text display-inline="no-display-inline">Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351 et seq.</external-xref>) is amended by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="HFEBA8827F42042FDB7347989ED4E13BE" style="OLC"> 
<section id="H0AE7AD1EF8D146A78DB916CBE0501C6E" commented="no"><enum>524B.</enum><header>Health software</header> 
<subsection id="H5BB78E5162A4412B930A4077F663F5AF" commented="no"><enum>(a)</enum><header>Inapplicability of regulation to health software</header><text display-inline="yes-display-inline">Except as provided in subsection (b), health software shall not be subject to regulation under this Act.</text></subsection> <subsection id="H53A8625165684FE7B65F0C017FFF144D" commented="no"><enum>(b)</enum><header>Exception</header> <paragraph id="H5F57E683125D40F38F18390EABFC0695"><enum>(1)</enum><header>In general</header><text>Subsection (a) shall not apply with respect to a software product—</text> 
<subparagraph id="HD4F83587D9E54EC2B13D5ABE63FEEC8F"><enum>(A)</enum><text>of a type described in subparagraph (F) of section 201(ss)(1); and</text></subparagraph> <subparagraph id="HC03342DF8F054797BC87E80548A35965"><enum>(B)</enum><text>that the Secretary determines poses a significant risk to patient safety.</text></subparagraph></paragraph> 
<paragraph id="H2EAFE4C58DE142DFAC6B7C9C78FFFC20"><enum>(2)</enum><header>Considerations</header><text>In making a determination under subparagraph (B) of paragraph (1) with respect to a product to which such paragraph applies, the Secretary shall consider the following:</text> <subparagraph id="H42E6E636B33F421FB1DFA8B06863130E" commented="no"><enum>(A)</enum><text display-inline="yes-display-inline">The likelihood and severity of patient harm if the product were to not perform as intended.</text></subparagraph> 
<subparagraph id="H6F2AEA63442F4F879296B4BED566331D" commented="no"><enum>(B)</enum><text display-inline="yes-display-inline">The extent to which the product is intended to support the clinical judgment of a medical professional.</text></subparagraph> <subparagraph id="H3441AF6912324562B56603BC4EF72FCC" commented="no"><enum>(C)</enum><text display-inline="yes-display-inline">Whether there is a reasonable opportunity for a medical professional to review the basis of the information or treatment recommendation provided by the product.</text></subparagraph> 
<subparagraph id="H674EA06A8066454AAA68F13196B4FFE7" commented="no"><enum>(D)</enum><text display-inline="yes-display-inline">The intended user and user environment, such as whether a medical professional will use a software product of a type described in subparagraph (F) of section 201(ss)(1).</text></subparagraph></paragraph></subsection> <subsection id="HF2B89A7C888D4852A8BB9D964CB3B823" display-inline="no-display-inline" commented="no"><enum>(c)</enum><header>Delegation</header><text display-inline="yes-display-inline">The Secretary shall delegate primary jurisdiction for regulating a software product determined under subsection (b) to be subject to regulation under this Act to the center at the Food and Drug Administration charged with regulating devices. <italic></italic></text></subsection> 
<subsection id="HCC6695C612D946BE82D4201EC4B3021F" commented="no"><enum>(d)</enum><header>Regulation of software</header> 
<paragraph id="H6530DE5A7B184AC091125D263751AC2F" commented="no"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall review existing regulations and guidance regarding the regulation of software under this Act. The Secretary may implement a new framework for the regulation of software and shall, as appropriate, modify such regulations and guidance or issue new regulations or guidance. </text></paragraph> <paragraph id="HB8DF6025AF0F4EF5945E5D39E4EF5010" commented="no"><enum>(2)</enum><header>Issuance by order</header><text>Notwithstanding subchapter II of <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/5/5">chapter 5</external-xref> of title 5, United States Code, the Secretary may modify or issue regulations for the regulation of software under this Act by administrative order published in the Federal Register following the publication of a proposed order.</text></paragraph> 
<paragraph id="HC218E6D263C74A95A62725DAD05B3C0A" commented="no"><enum>(3)</enum><header>Areas under review</header><text>The review of existing regulations and guidance under paragraph (1) may include review of the following areas:</text> <subparagraph id="H74754C6D727D4119AD32B8F5488726E3" commented="no"><enum>(A)</enum><text display-inline="yes-display-inline">Classification of software.</text></subparagraph> 
<subparagraph id="HC6438C27FB9B4EAB92AD1F5A1EAD2454" commented="no"><enum>(B)</enum><text>Standards for development of software.</text></subparagraph> <subparagraph id="HB8E51F8D8B1742B997C2532982915906" commented="no"><enum>(C)</enum><text>Standards for validation and verification of software.</text></subparagraph> 
<subparagraph id="HEAB8ACA257844B5896B50EF360EF8726" commented="no"><enum>(D)</enum><text>Review of software.</text></subparagraph> <subparagraph id="HF35F7C2A15C34C7C8E3AF5454E4CE318" commented="no"><enum>(E)</enum><text>Modifications to software.</text></subparagraph> 
<subparagraph id="H98F412528869452B829A696E11FFF0C5" commented="no"><enum>(F)</enum><text>Manufacturing of software.</text></subparagraph> <subparagraph id="H2C20ACBCD7754776ABAF07629B062134" commented="no"><enum>(G)</enum><text>Quality systems for software.</text></subparagraph> 
<subparagraph id="H1D05C985DE29457D94F1B4A97E2492B7" commented="no"><enum>(H)</enum><text>Labeling requirements for software.</text></subparagraph> <subparagraph id="HEAFA07EA80E34377B8C007D6DDD47DF8" commented="no"><enum>(I)</enum><text>Postmarketing requirements for reporting of adverse events.</text></subparagraph></paragraph> 
<paragraph id="H47EF88BF7EB34C5BA12A098F167E8076" commented="no"><enum>(4)</enum><header>Process for issuing proposed regulations, administrative order, and guidance</header><text display-inline="yes-display-inline">Not later than 18 months after the date of enactment of this section, the Secretary shall consult with external stakeholders (including patients, industry, health care providers, academia, and government) to gather input before issuing regulations, an administrative order, and guidance under this subsection.</text></paragraph></subsection> <subsection id="H3A1B1A0B409444E097BCBA8B5BC26D31"><enum>(e)</enum><header>Rule of construction</header><text display-inline="yes-display-inline">Nothing in this section shall be construed as providing the Secretary with the authority to regulate under this Act any health software product of the type described in subparagraph (F) of section 201(ss)(1) unless and until the Secretary has made a determination described in subsection (b)(1)(B) with respect to such product. </text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></section> 
<section id="H292C1BD61A354BB58F6557807FF73E89" commented="no"><enum>4.</enum><header>Exclusion from definition of device</header><text display-inline="no-display-inline">Section 201(h) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>) is amended—</text> <paragraph id="H789DEB9A064F44D79C6FBC7E81B86326" commented="no"><enum>(1)</enum><text>in subparagraph (2), by striking <quote>or</quote> after <quote>or other animals,</quote>;</text></paragraph> 
<paragraph id="H4CD13A78ABB44FB9A99044F20BCC5FCC" commented="no"><enum>(2)</enum><text>in subparagraph (3), by striking <quote>and</quote> and inserting <quote>or</quote>; and</text></paragraph> <paragraph id="H32496935DAC847DFA532E871F9D96B9F" commented="no"><enum>(3)</enum><text>by inserting after subparagraph (3) the following:</text> 
<quoted-block display-inline="no-display-inline" id="H736F118DED74483DB1906F329501366B" style="OLC"> 
<paragraph id="H0CA24702B71B442DA80247102A6ABA07" commented="no"><enum>(4)</enum><text display-inline="yes-display-inline">is not health software (other than software determined to be a risk to patient safety under section 524B(b)), and</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section> </legis-body> </bill> 

